Board Of Directors

Sharon Starowicz

President and Industry Representative, FDA Orthopaedic and Rehabilitation Devices Advisory Panel

Sharon Starowicz has served as President of OSMA since 2011 and was nominated as the Industry Representative to the FDA Orthopaedic and Rehabilitation Devices Advisory Panel in 2017.  Sharon is the Director of Regulatory Policy Innovation, Global Orthopaedics, for Johnson & Johnson, where she is responsible for providing strategic regulatory guidance and expertise and, with a focus on the external environment, shaping the evolving global regulatory policies that impact the medical device industry. She has over 30 years of regulatory affairs experience, specializing in Class I, II and III orthopedic and spinal devices.  Sharon is also a member of the AAOS Orthopaedic Device Forum.

Lisa Boyle


Lisa has 18 years experience in the medical device field, working to bring all classifications of products to market and maintaining post-market compliance obligations. Her recent roles with Aesculap Inc., and Aesculap Implant Systems, LLC., have included RA management with over site and responsibility for the Spinal, Ortho, Neuro, and Surgical Specialty products. Lisa has actively worked with OSMA since 2007. In 2016, Lisa was appointed to the OSMA board as Secretary.  

Susan Krasny, PhD, RAC

Past President

Susan is Vice President, Regulatory Affiars for Stryker Corporation.  Susan has over 30 years total experience in medical devices and 18 years in orthopedic regulatory, quality and clinical leadership roles. She is currently responsible for advocacy as Stryker’s primary regulatory representative to AdvaMed, MDMA and OSMA as well as establishing regulatory policies and standardized process across Stryker. Sue has served on the Board of OSMA as President, Past President, Vice President, Secretary and Board member and has lead multiple OSMA Task Force efforts, especially those related to downclassification of selected spinal devices. 

Carolyn Shelton

Board Member

Carolyn is the Vice President, Regulatory Affairs for Medtronic Spine and Biologics. She joined Medtronic in February 2014, bringing with her 29+ years of regulatory and quality experience. Prior to joining Medtronic, she was the Global Vice President of Regulatory Affairs at Smith & Nephew. Carolyn is also active with Life Science Tennessee and represents industry at the American Academy of Orthopaedic Surgeons (AAOS) Device Forum. 

Stacey Bonnell, MBA, RAC

Board Member

Stacey is Associate Director Regulatory Affairs Biomaterials / Front End Innovation for J&J DePuy Synthes and has extensive experience in the medical device field, working to bring all classifications of products to market and maintaining post-market compliance obligations. Her recent roles with Johnson and Johnson have included RA management with responsibility for Spinal orthopedic products, Regulatory Compliance with focus on Outreach and remediation, and most recently with oversight of Biomaterials portfolios while executing Front End Innovation strategies. Stacey’ has actively worked with OSMA since 2005, although her Board appointment began in 2014.  “OSMA brings together comradery, policy-shaping and advocacy… the perfect blend for any Regulatory enthusiast!”

Kathy Reddig, MS, RAC

Board Member

Kathy is the Director of Global Regulatory Affairs at ConMed Corporation. She has prior experience with Clinical and Regulatory Affairs at both Smith & Nephew Inc. and Medtronic Vascular. Kathy holds a Masters of Science in Regulatory Affairs from Northeastern University and a Bachelor of Science – Pre-medical in Biology from Rivier College in New Hampshire. She holds a RAC certification, an ISO Lead Auditor Certification, and is an active member of the Tampa RAPS Chapter. Kathy is also a part time faculty member in the graduate Regulatory Affairs program at Northeastern University in Boston, MA

Rodney Parker, Ph.D.

Board Member

Dr. Parker is Senior Principal Scientist in the Instrument Division of Stryker Corporation.  In this role, he is responsible for research on a variety of topics.  He holds an undergraduate degree in medical technology, a master’s degree in biomedical engineering and a PhD in business.  Dr. Parker worked in pharmaceutical toxicology research for 18 years before joining Stryker in 1995.  At Stryker, he has functioned in the roles of microbiologist, Regulatory Affairs Manager, and Clinical Affair/Sciences Manager before assuming his current role.  He is a current member for numerous ISO, ASTM, AAMI and Canadian Standards Association technical standards committees.